BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KJ015 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KJ015\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07036185-2579@assetmemo.bio
DTSTAMP:20261121T005844Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:KJ015: Phase 1 readout est. (NCT07036185)
DESCRIPTION:KJ015\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Clinica
 l Trail of KJ015 in Patients With HER2-Expressing Solid Tumors\nEstimated 
 primary completion: 31 December 2026. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/kj015#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT07036185
URL:https://assetmemo.bio/drug/kj015#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
